From Medscape Nephrology

Coverage from the

International Society of Nephrology (ISN): 2019 World Congress

April 12 - 15, 2019; Melbourne, Australia

April 12 - 15, 2019 Melbourne, Australia
  • ISN 2019 Diabetes Drug 'Home Run' Curtailing Kidney Failure Risk Canagliflozin also showed cardiovascular benefits in the CREDENCE multicenter trial, with no imbalance in adverse events, investigators shared here at the nephrology world congress.

Conference News

Popular Nephrology News

Medscape Nephrology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage